New drug is gamechanger in psoriasis treatment
A novel drug almost entirely cleared moderate to severe psoriasis in over 60% of the patients who took part in two phase three clinical trials of a new drug.
Apr 26, 2021
0
12
A novel drug almost entirely cleared moderate to severe psoriasis in over 60% of the patients who took part in two phase three clinical trials of a new drug.
Apr 26, 2021
0
12
(HealthDay)—For moderate-to-severe plaque psoriasis, bimekizumab is more efficacious than ustekinumab and placebo, according to a study published in the Feb. 6 issue of The Lancet.
Feb 5, 2021
0
2
(HealthDay)—For patients with psoriasis, smoking has negative effects, including increased frequency of nail involvement and cardiovascular diseases and higher psoriasis area and severity index, according to a study published ...
Oct 30, 2020
0
2
(HealthDay)—There are sex- and gender-specific differences related to clinical characteristics and quality-of-life (QoL) measures in patients with psoriasis, according to a study published online March 14 in Clinical and ...
Apr 10, 2020
0
2
(HealthDay)—Biologics seem to be associated with greater reduction in psoriasis severity scores and higher drug survival rates than methotrexate in pediatric patients treated in a real-world setting, according to a study ...
Feb 10, 2020
0
23
New results from a prospective, 12-month study indicate that the severity of psoriasis is associated with the severity of non-alcoholic fatty liver disease (NAFLD).
Oct 10, 2019
0
0
Researchers have found that anti-inflammatory biologic therapies used to treat moderate to severe psoriasis can significantly reduce coronary inflammation in patients with the chronic skin condition. Scientists said the findings ...
Jul 31, 2019
0
13
(HealthDay)—Patient-reported symptoms of psoriasis, quality of life, and work productivity worsen with increasing disease severity, as measured by two established clinician assessment tools, according to a study published ...
May 2, 2019
0
1
(HealthDay)—The Dermatology Life Quality Index (DLQI) may underestimate disease severity in patients with psoriasis who respond "not relevant" to one or more items, according to a research letter published online April ...
Apr 11, 2019
0
0
(HealthDay)—Depending on the definition used, there are large variations in the proportion of patients identified as having moderate-to-severe psoriasis, according to a study published in the December issue of the British ...
Jan 4, 2019
0
1